All View

Product Information BR-1306_PI_01.pdf
Registration Number BR-1306
Generic Name Quadrivalent Seasonal Influenza Vaccine (Split Virion, Inactivated) Southern Hemisphere 2024 Strain
Brand Name Vaxigrip Tetra
Dosage Strength influenza strains*: A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238) A/Thailand/8/2022 (H3N2)-like strain (A/California/122/2022, SAN-022) 15 μg of HA** 15 μg of HA* *** 15 μg of HA** B/Austria/1359417/2021 (B/Victoria lineage)-like virus (B/Michigan/01/2021, wild type) B/Phuket/3073/2013 (B/Yamagata lineage)-like virus (B/Phuket/3073/2013, wild type) *Propagated in fertilized hen's eggs from healthy chicken flocks **Haemagglutinin 15 μg of HA**
Dosage Form Suspension for Injection (IM/SC)
Classification Prescription Drug (RX)
Packaging 0.5 mL in 1 mL Type I pre-filled glass syringe with chlorobutyl plunger stopper and needle (Box of 1's).
Pharmacologic Category Vaccines
Manufacturer Sanofi Pasteur
Country of Origin France
Importer Sanofi Pasteur, Inc.
Distributor Zuellig Pharma Corporation
Application Type Monitored Release (Strain Clearance)
Issuance Date 19 February 2024
Expiry Date 19 February 2025